M N Blackburn

874 total citations
13 papers, 737 citations indexed

About

M N Blackburn is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, M N Blackburn has authored 13 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cell Biology and 3 papers in Oncology. Recurrent topics in M N Blackburn's work include Proteoglycans and glycosaminoglycans research (7 papers), Fibroblast Growth Factor Research (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). M N Blackburn is often cited by papers focused on Proteoglycans and glycosaminoglycans research (7 papers), Fibroblast Growth Factor Research (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). M N Blackburn collaborates with scholars based in United States, Australia and Canada. M N Blackburn's co-authors include Cynthia B. Peterson, T K Hart, Michael Brigham‐Burke, Parnian Zia‐Amirhosseini, Richard M. Cook, Robert L. Smith, John H. Carson, William T. Morgan, Kenneth G. Mann and ME Nesheim and has published in prestigious journals such as Journal of Biological Chemistry, Thrombosis and Haemostasis and Clinical & Experimental Immunology.

In The Last Decade

M N Blackburn

13 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M N Blackburn United States	11	283	248	191	182	136	13	737
Timothy J. Ernst United States	7	188 0.7×	494 2.0×	57 0.3×	123 0.7×	178 1.3×	8	955
Uwe Jerke Germany	13	104 0.4×	232 0.9×	222 1.2×	40 0.2×	155 1.1×	18	639
Fred Elfman United States	14	57 0.2×	328 1.3×	125 0.7×	37 0.2×	114 0.8×	21	600
Floortje L. Kessler Netherlands	11	168 0.6×	214 0.9×	77 0.4×	119 0.7×	86 0.6×	19	512
RN Buick Canada	11	417 1.5×	381 1.5×	132 0.7×	66 0.4×	32 0.2×	19	857
Geneviève Fiol France	13	412 1.5×	489 2.0×	94 0.5×	83 0.5×	63 0.5×	16	1.1k
Nandini Mondal United States	11	91 0.3×	380 1.5×	66 0.3×	51 0.3×	99 0.7×	13	657
Bernd Muehlenweg Germany	14	123 0.4×	232 0.9×	294 1.5×	41 0.2×	76 0.6×	19	555
Claus Fittschen United States	9	42 0.1×	271 1.1×	74 0.4×	53 0.3×	219 1.6×	18	586
Mariagrazia Ruvoletto Italy	17	56 0.2×	319 1.3×	206 1.1×	93 0.5×	21 0.2×	47	885

Countries citing papers authored by M N Blackburn

Since Specialization

Citations

This map shows the geographic impact of M N Blackburn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M N Blackburn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M N Blackburn more than expected).

Fields of papers citing papers by M N Blackburn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M N Blackburn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M N Blackburn. The network helps show where M N Blackburn may publish in the future.

Co-authorship network of co-authors of M N Blackburn

This figure shows the co-authorship network connecting the top 25 collaborators of M N Blackburn. A scholar is included among the top collaborators of M N Blackburn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M N Blackburn. M N Blackburn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hart, T K, et al.. (2002). Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clinical & Experimental Immunology. 130(1). 93–100. 160 indexed citations

Maksel, Danuta, et al.. (1999). Methanetrisphosphonate and its adenine nucleotide derivatives as inhibitors of human and plant diadenosine tetraphosphate hydrolases. Cellular & Molecular Biology Letters. 4(3). 4 indexed citations

Feuerstein, G, John R. Toomey, Richard E. Valocik, et al.. (1999). An Inhibitory Anti-factor IX Antibody Effectively Reduces Thrombus Formation in a Rat Model of Venous Thrombosis. Thrombosis and Haemostasis. 82(11). 1443–1445. 41 indexed citations

Peterson, Cynthia B., et al.. (1987). LYSINE-125 IS ESSENTIAL FOR HEPARIN BINDING TO ANTITHROMBIN. Thrombosis and Haemostasis. 1 indexed citations

Peterson, Cynthia B., et al.. (1987). Identification of a lysyl residue in antithrombin which is essential for heparin binding.. Journal of Biological Chemistry. 262(17). 8061–8065. 63 indexed citations

Peterson, Cynthia B., William T. Morgan, & M N Blackburn. (1987). Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding.. Journal of Biological Chemistry. 262(16). 7567–7574. 51 indexed citations

Peterson, Cynthia B. & M N Blackburn. (1987). Antithrombin conformation and the catalytic role of heparin. II. Is the heparin-induced conformational change in antithrombin required for rapid inactivation of thrombin?. Journal of Biological Chemistry. 262(16). 7559–7566. 33 indexed citations

Peterson, Cynthia B. & M N Blackburn. (1987). Antithrombin conformation and the catalytic role of heparin. I. Does cleavage by thrombin induce structural changes in the heparin-binding region of antithrombin?. Journal of Biological Chemistry. 262(16). 7552–7558. 18 indexed citations

Nesheim, ME, et al.. (1986). Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.. Journal of Biological Chemistry. 261(7). 3214–3221. 62 indexed citations

10.

Peterson, Cynthia B. & M N Blackburn. (1985). Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding.. Journal of Biological Chemistry. 260(1). 610–615. 126 indexed citations

11.

Blackburn, M N, et al.. (1984). Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III.. Journal of Biological Chemistry. 259(2). 935–938. 38 indexed citations

12.

Blackburn, M N, et al.. (1984). The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.. Journal of Biological Chemistry. 259(2). 939–941. 83 indexed citations

13.

Blackburn, M N, et al.. (1980). The heparin binding site of antithrombin III. Evidence for a critical tryptophan residue.. Journal of Biological Chemistry. 255(3). 824–826. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact